Seth A. Wander MD, PhD

Dr. Seth Wander is a medical oncologist at the Massachusetts General Hospital with a clinical and translational research interest in breast cancer and cancer genomics. Dr. Wander completed his undergraduate degree at Cornell University, where he studied Molecular and Cell Biology and graduated magna cum laude with distinction in research. He pursued his MD and PhD in Cancer Biology at the University of Miami. Dr. Wander completed his internship and residency in internal medicine at the Massachusetts General Hospital and his fellowship training in medical oncology at the Dana-Farber Cancer Institute and the Massachusetts General Hospital Cancer Center.

Dr. Wander's research is focused upon unraveling genomic mechanisms of resistance to targeted therapies in metastatic breast cancer. He has published more than fifty peer-reviewed manuscripts focused on the emerging field of precision medicine and related topics in oncology. He is an assistant professor of medicine at Harvard Medical School and remains engaged in teaching medical students, residents, and fellows. Dr. Wander, as part of a multidisciplinary team, leads a variety of clinical trials focused on developing novel clinical strategies for patients with metastatic breast cancer and resistance to standard hormonal and targeted agents. He has presented educational sessions and original research both nationally and internationally related to drug resistance and the development of personalized treatment strategies for breast cancer.